A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

NCT03776539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Impaired Renal Function

Interventions

DRUG: ELX-02

Sponsor

Eloxx Pharmaceuticals, Inc.

Collaborators

[object Object]